Newsroom

Sorted by: Latest

-

Rapid Medical™的DISTALS试验结果极为积极,证实TIGERTRIEVER™ 13对治疗中血管卒中具有卓越的再灌注效果

美国新奥尔良与以色列约克尼姆--(BUSINESS WIRE)--(美国商业资讯)-- 领先的动脉内介入器械开发商Rapid Medical™今日公布了DISTALS多中心随机对照试验的最新突破性结果。该研究显示,在治疗中血管闭塞(MVO)卒中时,TIGERTRIEVER™ 13系统相较于保守治疗能实现更优的脑组织再灌注效果,且具有卓越的安全性。该研究成果已在2026年国际卒中大会(ISC)闭幕主会场进行展示。 顶线结果数据显示,TIGERTRIEVER™ 13组在无症状性颅内出血(sICH)情况下成功再灌注的比例是药物治疗组的3倍——86.3% vs 27.7%(pp < 0.001)。值得注意的是,接受TIGERTRIEVER 13治疗的随机治疗组未报告任何sICH事件。相比之下,仅采用静脉溶栓治疗的sICH发生率更高,在近期临床试验中报告值为2%至6%1,2,3。 “这些结果凸显了当设备和试验均针对远端卒中专门设计时所能实现的突破。”DISTALS研究首席研究员Jeffrey L. Saver医学博士表示,“DISTALS专为远端卒中量身打造,将专为细小脆弱血管设计的装置与...
-

Die DISTALS-Studie von Rapid Medical™ ist äußerst positiv und belegt eine überlegene Reperfusion mit TIGERTRIEVER™ 13 bei Schlaganfällen in mittleren Gefäßen

NEW ORLEANS & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical™, ein führender Entwickler von aktiven endovaskulären Geräten, hat heute die neuesten Ergebnisse der multizentrischen, randomisierten kontrollierten Studie DISTALS bekannt gegeben, die zeigen, dass TIGERTRIEVER™ 13 im Vergleich zur medizinischen Behandlung bei Schlaganfällen mit mittlerer Gefäßokklusion (MVO) eine überlegene Reperfusion des Hirngewebes mit einem ausgezeichneten Sicherheitsprofil erzielt. Die Ergebnisse wurden in der...
-

Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium

IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson announced 12-month pilot-phase data from the OMNY-AF study and highlighted new findings related to the VARIPULSE Platform....
-

Glancy Prongay Wolke & Rotter Scores Top Securities Settlement of 2025

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (GPWR) is proud to announce that the Firm, as sole lead counsel for Alibaba investors, attained the highest securities class action settlement of 2025, according to prominent national economic consulting firm, NERA. Spearheaded by partners Kara Wolke and Melissa Wright, GPWR leveraged its deep experience and tenacious advocacy into a $433.5 million settlement for the benefit of Alibaba’s investors. Injured by fraud or corporate...
-

Linqto Receives Court Confirmation of Reorganization Plan and Sets Stage for Emergence from Chapter 11 Bankruptcy Protection in Coming Weeks

SAN JOSE, Calif. & HOUSTON--(BUSINESS WIRE)--Linqto, Inc. today announced that the Company’s Plan of Reorganization (“the Plan”) was confirmed by the United States Bankruptcy Court for the Southern District of Texas. With this approval in place, the Company expects the Plan to be effective and to emerge from Chapter 11 as soon as practicable. Last week, Linqto announced that customers overwhelmingly voted to approve the Company’s Chapter 11 bankruptcy plan, with more than 95% of the customers w...
-

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Paysafe Limited Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Paysafe Limited (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025. Paysafe provides end-to-end payment solutions in the United States and internationally. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Pa...
-

Resumen: TIGERTRIEVER™ 13 logra una reperfusión superior en ictus de vasos medianos, según ensayos DISTALS de Rapid Medical™

NUEVA ORLEANS & YOKNEAM, Israel--(BUSINESS WIRE)--Rapid Medical™, empresa líder en el desarrollo de dispositivos endovasculares activos, ha anunciado hoy los resultados preliminares del ensayo multicéntrico aleatorizado DISTALS, que muestran que TIGERTRIEVER™ 13 logró una reperfusión superior del tejido cerebral, con un perfil de seguridad destacado frente al manejo médico en ictus por oclusión del vaso mediano (MVO). Los hallazgos fueron presentados durante la sesión principal de clausura de l...
-

The U.S. EPA Announces New Registration for Low-Volatility Dicamba Herbicides

ST. LOUIS--(BUSINESS WIRE)--Today, the U.S. Environmental Protection Agency (EPA) announced a new federal registration for 34 states for low-volatility dicamba herbicides. This registration will enable U.S. farmers to have access to this important weed control tool in dicamba-tolerant soybeans and cotton. “We welcome the EPA’s scientific review and registration decision for low-volatility dicamba herbicides,” said Brian Naber, president of North America & Australia/New Zealand Region, Crop...
-

Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025. PomDoctor describes itself as a “leading online medical services platform for chronic diseases in China.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations...
-

RALLIANT CORPORATION INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Ralliant Corporation (“Ralliant” or the “Company”) (NYSE:RAL). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 4, 2026, Ralliant reported fourth quarter and full year 2025 results, revealing a “$1.4 b...